图文展示
 
药物研发思路的变革--从患者到患者(From Patient To Patient)
 
自由容器
Most of the product failures in phase ll and III trials are because resear chers are unable to demonstrate efficacy or sufticient satety.

图示:无法证明疗效是新药临床 II 期和 III期失败的主要原因
 
图文展示